Chennai Meenakshi Multispeciality Hospital's Q4 2023 Financial Results Show Mixed Performance

Chennai Meenakshi Multispeciality Hospital, a microcap healthcare services company, recently announced its financial results for the quarter ending December 2023. The company's stock call has been marked as 'Sell' by MarketsMOJO.

According to the financial report, Chennai Meena's performance for the quarter has been flat, with a score of -3 compared to -1 in the previous three months. However, there are some positive aspects to the company's financials. The net sales for the quarter were the highest in the last five quarters, at Rs 7.71 crore, and the near-term sales trend is positive.

On the other hand, there are some areas of concern for Chennai Meena. The operating profit (PBDIT) for the quarter was the lowest in the last five quarters, at Rs 0.27 crore, and the near-term trend for operating profit is negative. The operating profit margin for the quarter was also the lowest in the last five quarters, at 3.50%, indicating a decline in the company's efficiency. The profit before tax less other income (PBT) for the quarter was also the lowest in the last five quarters, at Rs -0.26 crore, and the near-term trend for PBT is negative. Additionally, the earnings per share (EPS) for the quarter were the lowest in the last five quarters, at Rs -0.05, showing a decline in profitability and lower earnings for shareholders.

Overall, Chennai Meenakshi Multispeciality Hospital's financial performance for the quarter ending December 2023 has been lackluster, with a 'Sell' recommendation from MarketsMOJO. Investors should carefully consider these factors before making any decisions regarding the company's stock.